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Aim: Complete surgical resection is the most effective treatment in early stage
non-small cell lung cancer. However, as many as 50 % of patients eventually recur and
die because of their disease. In addition, currently used prognostic markers are
imperfect to estimate the patients with high risk of relapse. One of the main roles of
immune system, immune surveillance, is to detect and destroy the tumor cells.
Therefore, it is suggested that deficiency in immune surveillance may play important
role in disease relapse. Main aim of the present study is to explore whether
semi-quantitatively measured rate of T-regulatory cell to total T lymphocyte with
immunohistochemical method in the primary tumor tissue is related with disease
relapse and have a prognostic role.
Methods: The present study was approved by our institutional ethic committee and
review board. Diagnostic work-up included the history, physical examination and
radiological evaluation. Pathologist reviewed ten separate fields for each slide, and an
average immunohistochemical score was recorded for each patient.
Results: A total 62 patients, 52 (83.9%) male and 10 (16.1%) female, were included.
Low risk, intermediate risk, and high risk score were detected in 29 (46.8%), 22
(35.5%), and 11 (17.7%) patients, respectively. There was significantly higher rate of
low risk score in patients who experienced disease relapse as compared to patients who
did not (p = 0.045). Overall survival rate was 81.2%, 73.3%, 65%, and 59% for 1, 2, 3
and 5 years, respectively. The statistical analysis was failed to show statistically
significant effect of risk scoring of T-reg/TIL on survival rate.In univariate analysis,
ECOG performance scale, pathological stage, primer tumor size, and lymph node stage
had statistically significant effect on overall survival.
Conclusions: In conclusion, result of the present study suggested that forming the risk
scoring group which used the rate of T-regulatory cells to total T lymphocytes could
not be used as a prognostic marker in early stage completely resected non-small cell
lung carcinoma.
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